JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 35.19.
| Share Price | ₹242.5 | Aug 26,2026 |
| Market Cap | ₹1,600.5 Cr | |
| Earnings-TTM | ₹45.5 Cr | TTM-Standalone Results |
| Price/Earnings | 35.19x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,600.5 Cr] as on Aug 26,2026
(/) Earnings [ ₹45.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 35.19x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 35.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 14.55x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 13.17x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 25.9x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 4.89x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| JAGSONPAL PHARMACEUTICALS | 45.48 | 35.19 | 1,600.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 37.47 | 456,114.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 81.82 | 239,321.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 86.24 | 185,924.0 |
| CIPLA LTD | 3,364.84 | 33.81 | 113,778.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.25 | 99,025.9 |
| MANKIND PHARMA LTD | 2,055.11 | 48.09 | 98,829.9 |
| LUPIN LTD | 5,551.01 | 18.05 | 100,196.0 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.49 | 114,508.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.14 | 93,326.3 |
| LAURUS LABS LTD | 1,090.76 | 93.52 | 102,011.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.05x |
| Max industry PE | 93.52x |
| Median industry PE | 35.19x |
| Average industry PE | 46.91x |
You may also like the below Video Courses